Athira Pharma Statistics
Total Valuation
Athira Pharma has a market cap or net worth of $19.40 million. The enterprise value is -$6.17 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Athira Pharma has 3.94 million shares outstanding. The number of shares has increased by 1.93% in one year.
| Current Share Class | 3.94M |
| Shares Outstanding | 3.94M |
| Shares Change (YoY) | +1.93% |
| Shares Change (QoQ) | +0.88% |
| Owned by Insiders (%) | 12.98% |
| Owned by Institutions (%) | 21.57% |
| Float | 2.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.68 |
| P/TBV Ratio | 0.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.70, with a Debt / Equity ratio of 0.03.
| Current Ratio | 9.70 |
| Quick Ratio | 9.05 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -89.42% and return on invested capital (ROIC) is -56.68%.
| Return on Equity (ROE) | -89.42% |
| Return on Assets (ROA) | -42.21% |
| Return on Invested Capital (ROIC) | -56.68% |
| Return on Capital Employed (ROCE) | -144.12% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.45M |
| Employee Count | 26 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.68% in the last 52 weeks. The beta is 2.97, so Athira Pharma's price volatility has been higher than the market average.
| Beta (5Y) | 2.97 |
| 52-Week Price Change | -27.68% |
| 50-Day Moving Average | 4.07 |
| 200-Day Moving Average | 3.61 |
| Relative Strength Index (RSI) | 61.34 |
| Average Volume (20 Days) | 21,943 |
Short Selling Information
The latest short interest is 66,316, so 1.68% of the outstanding shares have been sold short.
| Short Interest | 66,316 |
| Short Previous Month | 66,562 |
| Short % of Shares Out | 1.68% |
| Short % of Float | 2.58% |
| Short Ratio (days to cover) | 2.30 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -39.27M |
| Pretax Income | -37.72M |
| Net Income | -37.72M |
| EBITDA | -38.30M |
| EBIT | -39.27M |
| Earnings Per Share (EPS) | -$9.66 |
Full Income StatementBalance Sheet
The company has $25.23 million in cash and $912,000 in debt, giving a net cash position of $24.31 million or $6.16 per share.
| Cash & Cash Equivalents | 25.23M |
| Total Debt | 912,000 |
| Net Cash | 24.31M |
| Net Cash Per Share | $6.16 |
| Equity (Book Value) | 26.79M |
| Book Value Per Share | 6.79 |
| Working Capital | 24.24M |
Full Balance SheetCash Flow
| Operating Cash Flow | -52.35M |
| Capital Expenditures | n/a |
| Free Cash Flow | -52.35M |
| FCF Per Share | -$13.27 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
